| 359 |
Chitobiase inhibition leading to mortality |
Cataia Ives |
All rights reserved |
1807: Inhibition, Chitobiase
|
350: Increase, Mortality
|
Under Development |
1.94 |
| 360 |
Chitin synthase 1 inhibition leading to mortality |
Brendan Ferreri-Hanberry |
BY-SA |
1522: Inhibition, Chitin synthase 1
|
350: Increase, Mortality
|
WPHA/WNT Endorsed |
1.94 |
| 361 |
Sulfonylureareceptor binding leading to mortality |
Arthur Author |
All rights reserved |
1525: Increase, Sulfonylurea receptor binding
|
350: Increase, Mortality
|
Under Development |
1.94 |
| 362 |
Immune mediated hepatitis |
Agnes Aggy |
BY-SA |
1814: benzoquinone imine and acylglucuronide metabolites
|
1820: Immune mediated hepatitis
|
|
|
| 363 |
Thyroperoxidase inhibition leading to altered visual function via altered retinal layer structure |
Allie Always |
BY-SA |
279: Thyroperoxidase, Inhibition
|
2 AOs
|
Under Review |
1.35 |
| 364 |
Thyroperoxidase inhibition leading to altered visual function via decreased eye size |
Evgeniia Kazymova |
All rights reserved |
279: Thyroperoxidase, Inhibition
|
2 AOs
|
Under Development |
1.35 |
| 365 |
Thyroperoxidase inhibition leading to altered visual function via altered photoreceptor patterning |
Cataia Ives |
All rights reserved |
279: Thyroperoxidase, Inhibition
|
2 AOs
|
Under Development |
1.35 |
| 366 |
Competitive binding to thyroid hormone carrier protein transthyretin (TTR) leading to altered amphibian metamorphosis |
Brendan Ferreri-Hanberry |
BY-SA |
957: Binding, Transthyretin in serum
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 367 |
Competitive binding to thyroid hormone carrier protein thyroid binding globulin (TBG) leading to altered amphibian metamorphosis |
Arthur Author |
BY-SA |
1831: Binding, Thyroid binding globulin in serum
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 368 |
Cytochrome oxidase inhibition leading to increased nasal lesions |
Agnes Aggy |
BY-SA |
1840: Inhibition, cytochrome oxidase
|
2312: Increased, nasal lesions
|
|
|
| 369 |
Photosystem II antagonism leading to growth inhibition via oxidative damage |
Allie Always |
BY-SA |
None
|
None
|
|
|
| 370 |
Photosystem II antagonism leading to growth inhibition via suppression of photosynthesis |
Evgeniia Kazymova |
BY-SA |
None
|
None
|
|
|
| 371 |
Photosystem II antagonism leading to growth inhibition via dysregulation of growth hormone |
Cataia Ives |
BY-SA |
None
|
None
|
|
|
| 372 |
Androgen receptor antagonism leading to testicular cancer |
Brendan Ferreri-Hanberry |
BY-SA |
26: Antagonism, Androgen receptor
|
1839: Testicular Cancer
|
|
|
| 373 |
Mitochondrial dysfunction to metabolic diseases |
Arthur Author |
BY-SA |
None
|
None
|
|
|
| 374 |
Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on brain cells (neuronal and non-neuronal) leads to neuroinflammation resulting in encephalitis |
Agnes Aggy |
All rights reserved |
1739: Binding to ACE2
|
1841: Encephalitis
|
Under Development |
1.96 |
| 375 |
test AOP |
Allie Always |
BY-SA |
None
|
None
|
|
|
| 376 |
Androgen receptor agonism leading to male-biased sex ratio |
Evgeniia Kazymova |
BY-SA |
25: Agonism, Androgen receptor
|
360: Decrease, Population growth rate
|
WPHA/WNT Endorsed |
1.12 |
| 377 |
Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS) |
Cataia Ives |
BY-SA |
1842: Prolonged TLR9 activation
|
2 AOs
|
|
|
| 378 |
Dysregulated underperforming Toll Like Receptors (TLRs) leading to high pathogen load |
Brendan Ferreri-Hanberry |
BY-SA |
1848: Toll Like Receptor (TLR) Dysregulation
|
None
|
|
|
| 379 |
Binding to ACE2 leading to thrombosis and disseminated intravascular coagulation |
Arthur Author |
All rights reserved |
1739: Binding to ACE2
|
1846: Thrombosis and Disseminated Intravascular Coagulation
|
Under Development |
1.96 |
| 381 |
Binding of viral S-glycoprotein to ACE2 receptor leading to dysgeusia |
Agnes Aggy |
BY-SA |
1739: Binding to ACE2
|
1850: dysgeusia
|
Under Development |
1.96 |
| 382 |
Angiotensin II type 1 receptor (AT1R) agonism leading to lung fibrosis |
Allie Always |
BY-SA |
1851: Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)
|
1276: Lung fibrosis
|
Under Development |
1.96 |
| 383 |
Inhibition of Angiotensin-converting enzyme 2 leading to liver fibrosis |
Evgeniia Kazymova |
BY-SA |
1740: Induced dysregulation of ACE2
|
344: N/A, Liver fibrosis
|
Under Development |
1.96 |
| 384 |
Hyperactivation of ACE/Ang-II/AT1R axis leading to chronic kidney disease |
Cataia Ives |
BY-SA |
1853: Hyperactivation of ACE/Ang-II/AT1R axis
|
1603: Chronic kidney disease
|
|
|